Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Processa Pharmaceuticals, Inc. - Common Stock
(NQ:
PCSA
)
0.2397
+0.0050 (+2.13%)
Streaming Delayed Price
Updated: 3:54 PM EDT, May 19, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Processa Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Why Is Processa Pharmaceuticals (PCSA) Stock Up 29% Today?
July 30, 2024
Processa Pharmaceuticals stock is up on Tuesday as PCSA investors react to approval for a Phase 2 clinical trial of NGC-Cap.
Via
InvestorPlace
InvestorNewsBreaks – Processa Pharmaceuticals Inc.’s (NASDAQ: PCSA) IND Application for Phase 2 Clinical Trial of NGC-Cap in Patients with Breast Cancer Receives FDA Clearance
July 30, 2024
Via
Investor Brand Network
Exposures
Product Safety
Dow Jumps 200 Points; Pfizer Earnings Top Views
July 30, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Appoints Seasoned Veteran as Chief Financial Officer
July 17, 2024
Via
Investor Brand Network
Exposures
Product Safety
PCSA Stock Earnings: Processa Pharma Reported Results for Q1 2024
May 13, 2024
Processa Pharma just reported results for the first quarter of 2024.
Via
InvestorPlace
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Positive Efficacy Results from Phase 1b Trial
June 11, 2024
Via
Investor Brand Network
Exposures
Product Safety
BioMedNewsBreaks — Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Participation at Upcoming EF Hutton Global Conference
May 06, 2024
Via
Investor Brand Network
Exposures
Product Safety
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Appoints Dr. Steven Cha to Lead Clinical Development of Oncology Programs
April 30, 2024
Via
Investor Brand Network
Exposures
Product Safety
How Is The Market Feeling About Processa Pharma?
February 09, 2024
Via
Benzinga
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 26, 2024
Via
Benzinga
Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
April 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 26, 2024
Via
Benzinga
Crude Oil Moves Higher; Bristol Myers Squibb Shares Fall After Q1 Results
April 25, 2024
Via
Benzinga
Exposures
Fossil Fuels
12 Health Care Stocks Moving In Thursday's Intraday Session
April 25, 2024
Via
Benzinga
S&P 500 Down Over 1%; Merck Increases 2024 Outlook
April 25, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 25, 2024
Via
Benzinga
Dow Dips Over 500 Points; US GDP Growth Misses Expectations
April 25, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
April 12, 2024
Via
Benzinga
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Presents New Data from NGC-Cap Phase 1b Trial at AACR Annual Meeting
April 11, 2024
Via
Investor Brand Network
Exposures
Product Safety
12 Health Care Stocks Moving In Monday's After-Market Session
April 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
April 05, 2024
Via
Benzinga
BioMedNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at Upcoming MedInvest Conference
March 28, 2024
Via
Investor Brand Network
Exposures
Product Safety
TinyGemsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at Upcoming MedInvest Conference
March 28, 2024
Via
Investor Brand Network
Exposures
Product Safety
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Participation at American Association for Cancer Research Annual Meeting
March 25, 2024
Via
Investor Brand Network
Exposures
Product Safety
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at 2024 BIO CEO & Investor Conference
February 21, 2024
Via
Investor Brand Network
Exposures
Product Safety
Processa Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
February 08, 2024
The Dow Jones index closed higher by around 150 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Closes on $7M Public Offering
February 02, 2024
Via
Investor Brand Network
Exposures
Product Safety
Expensify And 3 Other Stocks Under $3 Insiders Are Buying
February 02, 2024
The Dow Jones index closed higher by more than 350 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Relmada Therapeutics And 2 Other Penny Stocks Insiders Are Buying
February 01, 2024
The Dow Jones index closed lower by more than 300 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.